1. Introduction[1](#fn0005){ref-type="fn"} {#s0005}
==========================================

Transient osteoporosis (TO) is characterized by self-limited joint pain and by the presence of bone marrow edema on magnetic resonance imaging (MRI). TO most commonly affects the hip[2](#fn0010){ref-type="fn"}, but has also been reported to involve the knee, ankle and foot ([@bb0070]). The presence of bone marrow edema (BME)[3](#fn0015){ref-type="fn"} on MRI is non-specific and is commonly reported in many conditions that affect the knee ([@bb0060]). We hypothesize that in many cases, BME on MRI actually represents unrecognized TO, and that TO of the knee is more common than previously reported, since a lack of clinical awareness of TO by many health care providers may lead them to misdiagnose subjects with severe, atraumatic knee pain. We propose that TO of the knee is a manifestation of the same process that occurs in the hip. Moreover, we postulate that the migratory nature of this syndrome as seen in some patients is a reflection of a disorder that may involve one or more joints with the hip being the most common site. In the absence of osteonecrosis, osteoarthritis or meniscal tears, TO of the knee should be strongly considered in the presence of BME, especially when the clinical manifestations subsequently resolve spontaneously. We present two cases of TO, one at the hip and one at the knee, to highlight the transient and self-resolving nature of this disorder and to demonstrate how advances in imaging and targeted bone mineral density tests can distinguish TO from other causes of BME.

2. Case \#1 {#s0010}
===========

A 35-year-old male presented to the NYU-Hospital for Joint Disease Osteoporosis Center with progressive pain in his left hip, limiting his ability to ambulate. He denied any antecedent event or trauma preceding the onset of pain. Initial X-rays showed marked demineralization of the left femoral head and neck. A subsequent MRI revealed diffuse bone marrow edema of the left femoral head and neck with a suggestion of a possible subchondral fracture and a moderate hip joint effusion. Bone densitometry of the left femoral neck revealed a BMD of 0.783 g/cm^2^ and a Z-score of − 2.5, compared with a normal right femoral neck bone density of 1.111 with a Z score of + 0.0 ([Fig. 1](#f0005){ref-type="fig"} A and B). A diagnosis of TO was made and the patient was empirically started on risedronate 35 mg once weekly, which he used weekly for twelve weeks. Additionally, he was started on calcium and vitamin D supplementation. Repeat radiographs after three months showed complete remineralization of the femoral head and neck. A repeat bone mineral density test now showed a normal left femoral neck bone mineral density of 1.014 g/cm^2^ and a Z score of − 0.8. His right femoral neck bone density remained normal ([Fig. 2](#f0010){ref-type="fig"} A and B). At that time, the patient reported complete resolution of his symptoms and was able to proceed with pain-free weight bearing.Fig. 1A: Left femoral neck BMD of 0.783 g/cm^2^ and a T-score of − 2.1; B: Normal right femoral neck bone density of 1.111 and a T score of + 0.Fig. 1Fig. 2A and B: Repeat BMD testing at 3 months revealing normal left and right femoral neck bone density.Fig. 2

Three years later, the patient developed a peroneus tendinitis of his right foot that required him to wear a cam walker. Within one month, he developed severe pain in his right hip and he was unable to bear weight on his right foot. Radiographs of the right hip were unremarkable. An MRI revealed diffuse bone marrow edema ([Fig. 3](#f0015){ref-type="fig"}) and a minimally depressed subchondral fracture at the anterosuperior femoral head, similar to the changes seen in the left hip three years prior. A bone density test revealed a right femoral neck BMD of 0.836 g/cm^2^ with a Z score of − 2.0. His left femoral bone density was normal ([Fig. 4](#f0020){ref-type="fig"} A and B). He was again empirically treated with a three month course of risedronate. His pain resolved completely two months after onset.Fig. 3MRI of right hip revealing diffuse bone marrow edema.Fig. 3Fig. 4Repeat BMD when patient presented with *right* hip pain. A: Normal left femoral neck BMD. B: Right femoral neck BMD of 0.836 g/cm^2^ with a T score of − 1.8.Fig. 4

2.1. Case \#2 {#s0015}
-------------

A 64-year-old, previously healthy male presented to his orthopedic surgeon with a two-week history of progressively increasing left knee pain. He localized the pain to the lateral aspect of the distal femur and complained that the pain increased after sitting for prolonged periods and with stair climbing. He denied any trauma to the knee but had recently increased his exercise regimen and reported that he had been running on a treadmill more frequently than he had previously done. A radiograph of the knee was unremarkable. An MRI of the left knee revealed marked bone marrow edema as well as a focal subchondral fracture in the weight-bearing region of the lateral femoral condyle ([Fig. 5](#f0025){ref-type="fig"}). In addition, a high-resolution 7 T MRI of his left distal femur revealed deterioration in bone microarchitecture (manifested by trabecular loss and disruption), as compared to the right. ([Fig. 6](#f0030){ref-type="fig"}). A regional knee bone mineral density test showed his left lateral femoral condyle BMD to be 0.96 g/cm^2^. Additional routine evaluation including ensuring adequate levels of 25-dihydroxyvitamin D, did not yield any abnormalities or areas for possible intervention. The patient did continued with routine calcium and vitamin D supplementation. The patient reported spontaneous resolution of his knee pain over the next month. A repeat regional knee bone density of the left lateral femoral condyle showed marked improvement with a BMD of 1.63 g/cm^2^ at one year follow up ([Fig. 7](#f0035){ref-type="fig"} A and B).Fig. 5MRI of the left knee revealing marked bone marrow edema and focal subchondral fracture in the weight-bearing region of the lateral femoral condyle.Fig. 5Fig. 6A: High resolution 7 T MRI revealing deterioration of bone microarchitecture in the affected left knee (boxes) compared to the unaffected right knee; B: Higher power view of microarchitectural changes affecting distal femur.Fig. 6Fig. 7A and B: Bone density of left distal femur showing regional osteopenia with marked improvement of BMD at one year follow up.Fig. 7

3. Discussion {#s0020}
=============

TO of bone is an uncommon, self-limited clinical syndrome, characterized by the acute onset of joint pain and the presence of bone marrow edema on MR imaging ([@bb0060], [@bb0020]). TO mainly affects healthy middle-aged men, and women in the third trimester of pregnancy. The bones/joints of the lower extremities are most commonly affected with the hip most frequently involved followed in order of frequency by the knee, foot and ankle ([@bb0070], [@bb0030]). Although it is most often unilateral a bilateral incidence of 20% (as seen in Cased \#1) has been reported in a Japanese study ([@bb0060], [@bb0025]).

Although the cause of TO is unknown, multiple etiopathogenic mechanisms have been proposed ([@bb0015]). The presence of a joint effusion in nearly all cases of TO suggests synovial involvement, but investigation has revealed only non-specific synovial fluid findings. A limited number of synovial biopsies performed in patients with TO have shown only mild inflammatory reactions ([@bb0035]). Based on common EMG findings it has also been suggested that TO is a variant of reflex sympathetic dystrophy ([@bb0020]). Yet a third hypothesis is that the TO effect on bone occurs secondary to a transient ischemic insult, suggesting that TO and osteonecrosis may exist on a spectrum ranging from transient and reversible bone injury to extensive bone death. However, in one study of 155 patients diagnosed with TO of the hip by imaging criteria, none of the patients progressed to osteonecrosis, casting doubt on the suggestion that TOH is part of a clinical spectrum that may result in either spontaneous resolution (TOH) or avascular bone death ([@bb0030], [@bb0025]). Moreover, none of the proposed pathogenic theories explain why there is an increased incidence of TO in men or pregnant women ([@bb0015]).

TOH most commonly presents with spontaneous and severe unilateral hip pain. The pain often progresses over several weeks. Patients characteristically deny any antecedent history of trauma. The pain is typically exacerbated by activity and weight bearing ([@bb0040]). Bone loss, as seen in our Case \#1, occurs most prominently in the femoral neck and head. Klontzas et al. retrospectively evaluated 155 hip joints in patients with confirmed TOH initially diagnosed by MR imaging. In this study, 87% of the MRIs showed sparing of the medial bone marrow of the femoral head. Only 11% of the MRIs showed BME restricted to femoral head. The femoral neck was involved in 49% of cases. Subchondral fractures were present in 48%, though, of note, no statistically significant association between the duration of symptoms and the presence of subchondral fractures was reported ([@bb0025]). In TO of the hip, the clinical trajectory can vary, but symptoms usually plateau after a few weeks and then gradually decline over the following 3--9 months until there is complete resolution of symptoms ([@bb0015]).

TO of the knee, though rarely reported in literature, has been described in the context of a bone marrow edema syndrome. A number of cases have reported this entity, with the classic resolution of bone marrow edema without intervention at twelve-month follow up. The femoral condyles have been the most common sites reported to be involved in this syndrome ([@bb0050], [@bb0055]). MRI may reveal a classic "crescent" region of increased signal intensity in the posterior potion of the lateral femoral condyle. This is a faint rim of low signal intensity on T1 weighted imaging and a more well-defined area of low signal intensity on T2 weighted images which has been thought to resemble the "fluid-like" changes described in osteonecrosis by Mitchell et al. TO of the knee has also been diagnosed by radioisotope bone scans that demonstrate increased radionuclide uptake in these focal regions ([@bb0030], [@bb0045]).

There are no biomarkers or other laboratory tests that are helpful in making a diagnosis of TO although some patients may have elevated acute phase reactants ([@bb0030]). The hallmark sign of TO on MRI is bone marrow edema. The T1 weighted images will show an ill-defined area of decreased signal intensity, with increased signal intensity on the T2 weighted images; T2 weighted imaging may also reveal a joint effusion. Bone marrow edema can be classified into two categories: reversible with conservative treatment such as TO, Regional Migratory Osteoporosis, chronic regional pain syndrome, trauma, and non-reversible such as avascular necrosis, infection, tumors and degenerative and inflammatory arthropathies ([@bb0015], [@bb0025]). These syndromes have all been reported to produce a similar pattern of bone marrow edema (BME) on MR. TO can be distinguished from other causes of bone marrow edema, particularly osteonecrosis, by its self-limited nature ([@bb0020]).

In our patient (Case \#2) who developed TO of the knee, we used bone densitometry of the distal femur to help confirm the diagnosis. To our knowledge, this is the first reported case using peripheral bone densitometry to confirm a diagnosis at the distal femur in TO. Our group has previously reported the utility of bone densitometry of the femoral neck by demonstrating marked bone loss and subsequent resolution back to a normal bone density with complete clinical remission ([@bb0010]). Case \#2 extends the use of this modality to regional bone sites and is now a routine part of our evaluation of patients with bone marrow edema who are referred to our facility. We have not seen localized bone loss in other patients with bone marrow edema of the knee including those with osteoarthritis, osteonecrosis and meniscal tears. The serial measurements seen in the bone density scans in both our cases correlated both with their clinical courses and the initial and follow up MRI scans showing resolution of the BMD. Of note, the study mentioned above (Klontzas et al.) did measure bone densitometry on 30 of their patients, of which 31 showed osteopenia and 30 showed osteoporosis, however these measurements were taken from the lumbar spine and not the site of pain and local bone loss ([@bb0025]). Additionally, we utilized a high-resolution 7 T MRI machine in Case \#2 which allowed us to clearly see the trabecular microarchitectural deterioration of his affected knee compared to his contralateral and uninvolved knee. This finding is, to our knowledge, the first reported use of this technology for this application.

Bone marrow edema is a common finding on MRI and is often see in patients with knee pain with a variety of clinical conditions. We believe that transient osteoporosis of the knee is likely the cause of knee pain in some of these patients particularly those who experience spontaneous resolution both of their knee pain and the BME seen on MRI. Regional bone density measurements confirm that localized bone loss occurs in both the hip and knee of patients with TO and that this bone loss is indeed transient in nature. Bone marrow edema of the knee appears to be found as a result of a number of conditions including meniscal tears, osteoarthritis, trauma and regional osteoporotic syndromes. Patients with bone marrow edema in association with transient osteoporosis often have severe pain, but the pain levels seen with these other conditions is quite variable ([@bb0020]).

Whether treatment with anti-resorptive agents affects the natural course of TO is unknown. Treatment with such agents including calcitonin and bisphosphonates has been reported to alleviate pain and accelerate both clinical and radiologic recovery. However, most of this data comes from case reports and uncontrolled case series ([@bb0005]). The rarity of this syndrome makes it unlikely that a randomized controlled trial assessing the therapeutic efficacy of any drug for TO will be conducted. Empiric treatment with anti-resorptive agent can be offered to patients with TO, as was done in Case \#1, but patients should know that there is no firm data suggesting that such treatment is effective. In the two patient\'s described, there were no quantified bone scans or bone markers to suggest increased turnover. These values have been checked in this specific population the past by our group and were not elevated.
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